Fysio Papendrecht, Papendrecht, The Netherlands.
Neurourol Urodyn. 2013 Mar;32(3):206-14. doi: 10.1002/nau.22296. Epub 2012 Aug 20.
To assess the effectiveness of percutaneous tibial nerve stimulation (PTNS) on adult patients with overactive bladder syndrome, using a systematic review of randomized controlled trials (RCTs), clinical controlled trials (CCTs), and prospective observational cohort studies.
A computer-aided literature search was performed in: PubMed, EMBASE and CENTRAL (2000 to November 15, 2011) to identify RCTs, CCTs, and prospective observational cohort studies. The study had to investigate the effect of PTNS on overactive bladder syndrome. The methodological quality of each study was assessed and a qualitative analysis was performed to establish the levels of evidence.
Four RCTs and six prospective observational cohort studies were identified. There is strong evidence for the efficacy of PTNS versus a sham treatment. There is limited evidence that the use of PTNS and tolterodine ER is equally effective. No additional effect of a combination of Stoller afferent nerve stimulation (SANS) and anticholinergic medication compared to SANS alone. Most cohort studies suggested decreased frequency and improvement of incontinence and nocturia. However, the level of evidence was insufficient to make any firm conclusions. Because the total duration of all included trials varied between 6 and 12 weeks, so far there is little information on treatment periods.
PTNS is efficacious for frequency and urgency urinary incontinence. More high quality studies are needed to improve the level of evidence concerning the efficacy of PTNS with regard to urgency and nocturia, to specify patient selection criteria, optimal treatment modalities and long-term effects as well as the effectiveness in more pragmatic trials.
通过对随机对照试验(RCT)、临床对照试验(CCT)和前瞻性观察队列研究的系统评价,评估经皮胫神经刺激(PTNS)对成年膀胱过度活动症患者的疗效。
计算机辅助检索PubMed、EMBASE 和 CENTRAL(2000 年至 2011 年 11 月 15 日),以确定 RCT、CCT 和前瞻性观察队列研究。研究必须调查 PTNS 对膀胱过度活动症的影响。评估每个研究的方法学质量,并进行定性分析以确定证据水平。
共确定了 4 项 RCT 和 6 项前瞻性观察队列研究。有强有力的证据表明 PTNS 优于假治疗。有有限的证据表明 PTNS 和托特罗定 ER 的使用同样有效。与单独使用 SANS 相比,Stoller 传入神经刺激(SANS)和抗胆碱能药物联合使用没有额外的效果。大多数队列研究表明,频率降低,失禁和夜尿症得到改善。然而,证据水平不足以得出任何明确的结论。由于所有纳入试验的总持续时间在 6 至 12 周之间,因此目前关于治疗期的信息很少。
PTNS 对频率和紧迫性尿失禁有效。需要更多高质量的研究来提高关于 PTNS 对紧迫性和夜尿症的疗效、确定患者选择标准、最佳治疗方式和长期效果以及在更实用的试验中的有效性的证据水平。